0 followers
Arch Therapeutics, Inc. (OTCQB:ARTH) is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care.
Industries
Headquarters
Stage
Employees
Links
View full screen
Terrence W. Norchi
View all
14 members
5 members
3 members
1 members
Coherus BioSciences
5 followers
BioMarin Pharmaceutical
20 followers
Adaptive Biotechnologies
11 followers
Eikon Therapeutics
1 follower
Dragonfly Therapeutics
Explore more companies